INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 143 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $142,000 | -27.9% | 13,000 | -7.8% | 0.10% | -34.0% |
| Q1 2015 | $197,000 | -22.7% | 14,100 | -6.6% | 0.15% | +7.3% |
| Q4 2014 | $255,000 | -9.9% | 15,100 | -28.4% | 0.14% | -9.9% |
| Q3 2014 | $283,000 | +22.5% | 21,100 | +16.6% | 0.15% | +32.2% |
| Q2 2014 | $231,000 | -3.3% | 18,100 | -10.0% | 0.12% | -9.4% |
| Q1 2014 | $239,000 | +7.7% | 20,100 | +24.8% | 0.13% | +5.0% |
| Q4 2013 | $222,000 | -18.4% | 16,100 | +3.2% | 0.12% | -21.4% |
| Q3 2013 | $272,000 | – | 15,600 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |